A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2002
11/13/2002	CN1379672A Highly selective norepinephrine reuptake inhibitors and methods of using same
11/13/2002	CN1379671A Treating sleep disorders using desloratadine
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379664A Activation and protection of cytotoxic lymphocytes using reactive oxygen metabolite inhibitor
11/13/2002	CN1378789A Application of medical feed for systematic treating fish disease
11/13/2002	CN1094126C Pyrroloazepine compounds
11/12/2002	US6479676 OxiranEcarboxylic acids for the treatment of diabetes
11/12/2002	US6479670 Selective retinoid acid receptor agonists
11/12/2002	US6479666 Phenyl-keto-imidazolidine thioamide derivatives
11/12/2002	US6479663 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/12/2002	US6479655 TNF receptor promoter
11/12/2002	US6479643 Single chain analogs of the TGF-β superfamily (morphons)
11/12/2002	US6479637 Hemoglobin-haptoglobin complexes
11/12/2002	US6479633 Chemokine alpha 2
11/12/2002	US6479630 Human purinergic P2U receptor
11/12/2002	US6479553 Use of certain affinity NMDA antagonists as antidepressants
11/12/2002	US6479549 Alzheimer's disease; antiischemic agents
11/12/2002	US6479540 Compositions of tocol-soluble therapeutics
11/12/2002	US6479538 Cyclic ether vitamin D3 compounds, 1α(OH)3-EPI-vitamin D3 compounds and uses thereof
11/12/2002	US6479534 Indoline derivatives and method of treating obesity
11/12/2002	US6479528 Methods for inhibiting or reversing tau filament formation polymerization
11/12/2002	US6479527 Bicyclic pyrrole derivatives as MCP-1 inhibitors
11/12/2002	US6479524 To prolong the thrombin time
11/12/2002	US6479523 Achieved by electrical stimulation of the vagus nerve and administration of a combination of drugs including: an acetylcholinesterase inhibitor, a beta-adrenergic receptor blocker, and a calcium channel blocker
11/12/2002	US6479519 Inhibitors of cell adhesion; treatment of asthma or inflammatory bowel disease
11/12/2002	US6479517 Treatment of post-menopausal syndrome: osteoporosis, cardiovascular effects such as hyperlipidemia, and estrogen-dependent cancer, particularly breast and uterine cancer
11/12/2002	US6479513 Anticancer compound and enantiomer separation method useful for synthesizing said compound
11/12/2002	US6479512 Tyrosine kinase inhibitors
11/12/2002	US6479510 N-((2s,3r)-2-methyl-1-azabicyclo(2.2.2)oct-3-yl)-4-(4-hydroxyp henoxy)- benzamide for example; treating diseases of the alpha-7-nicotinic acetylcholine receptor i.e. schizophrenia, or psychosis
11/12/2002	US6479508 Viral polymerase inhibitors
11/12/2002	US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002	US6479506 Triazolo-pyridine derivatives as ligands for GABA receptors
11/12/2002	US6479505 6-arylphenanthridines with PDE-IV inhibiting activity
11/12/2002	US6479502 Hydroxamic acid derivatives as proteinase inhibitors
11/12/2002	US6479500 Alleviating side effects caused by use of an anti-tumor agent comprising administering 5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidin edione
11/12/2002	US6479494 Arylalkanoyl pyridazines
11/12/2002	US6479492 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/12/2002	US6479490 Treatment of diseases characterized by excess th2 cytokines and/ or an excess ige production.
11/12/2002	US6479488 Good in vitro affinity for the strychnine insensitive glycine binding site associated with the nmda receptor complex but also good in vivo activity when administered systemically
11/12/2002	US6479487 6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
11/12/2002	US6479483 3,4,6-substituted pyridine derivatives useful for treating depression and pain, resulting from inflammatory conditions, such as migraine, rheumatoid arthritis, asthma and inflamatory bowel disease; nk1 receptor antagonist
11/12/2002	US6479481 Administering an effective dose of a cns tumor-inhibiting methylol transfer agent such as: taurolidine, taurultam or a mixture thereof.
11/12/2002	US6479477 Substituted porphyrins
11/12/2002	US6479474 Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
11/12/2002	US6479471 Novel phosphonate derivatives, hydroxyphosphinyl derivatives, and phosphoramidate derivatives that inhibit n-acetylated .alpha.-linked acidic dipeptidase (naaladase) enzyme activity to treat prostate diseases
11/12/2002	US6479470 Naag and naaladase have been implicated in several pathological conditions relating to glutamate abnormalities and neurotoxicity
11/12/2002	US6479469 N-acylated-2-glucosamine derivatives for treating osteoarthritis/inflammatory arthritis, and enhancing cartilage formulation, chondrocyte cell proliferation and glycosaminoglycan production
11/12/2002	US6479458 Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy
11/12/2002	US6479292 Genetic alteration in plants using single-stranded oligodeoxynucleotide vectors
11/12/2002	US6479270 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
11/12/2002	US6479266 IKK-α proteins nucleic acids and methods
11/12/2002	US6479265 Catalytic antibodies which hydrolyze primary amides and methods for eliciting and use of such antibodies
11/12/2002	US6479261 Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
11/12/2002	US6479250 Eck receptor ligands
11/12/2002	US6479080 Plant extract
11/12/2002	US6479078 Substantially crystalline form of melagatran
11/12/2002	CA2271781C Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
11/12/2002	CA2246839C Pharmaceutical compositions containing ampa receptor antagonists for treating dyskineslas associated with dopamine agonist therapy
11/12/2002	CA2169635C Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
11/12/2002	CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them
11/12/2002	CA2059558C Use of calcium antagonists for treating scars
11/12/2002	CA2055948C Use of a combination of angiotensin-converting enzyme inhibitor and calcium antagonist for the treatment of proteinuria
11/11/2002	CA2385692A1 Thiazole derivatives
11/07/2002	WO2002088383A2 Method and system for identifying targets by nucleocytoplasmic cycling and use thereof
11/07/2002	WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme
11/07/2002	WO2002088354A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	WO2002088343A2 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT)
11/07/2002	WO2002088336A2 Genetically modified yt cell line and use thereof
11/07/2002	WO2002088322A2 Cell adhesion and extracellular matrix proteins
11/07/2002	WO2002088318A2 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002	WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088180A2 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
11/07/2002	WO2002088172A2 Pentapeptide compounds and uses related thereto
11/07/2002	WO2002088167A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
11/07/2002	WO2002088156A1 Lipid a 1-carboxylic acid derivative
11/07/2002	WO2002088144A2 ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE
11/07/2002	WO2002088143A2 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
11/07/2002	WO2002088139A1 6h-oxazolo[4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
11/07/2002	WO2002088138A1 Novel 4-amino-5,6-substituted thiopheno[2,3-d]pyrimidines
11/07/2002	WO2002088137A1 Pkb-3564 substance with neovascularization inhibitory activity
11/07/2002	WO2002088131A1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta[a]naphthalene
11/07/2002	WO2002088122A1 Heterocyclic compounds
11/07/2002	WO2002088121A1 Pyrazolo[1,5-a]pyridines and medicines containing the same
11/07/2002	WO2002088115A1 Novel sulfonamide derivatives, intermediate thereof, its preparation methods, and pharmaceutical composition comprising the same
11/07/2002	WO2002088109A1 Crystal of 6-[4-(4-pyridylamino)phenyl]-4, 5-dihydro-3(2h)-pyridazinone hydrochloride trihydrate
11/07/2002	WO2002088108A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	WO2002088107A1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof
11/07/2002	WO2002088106A2 Cysteine protease inhibitors
11/07/2002	WO2002088097A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002088094A1 2-iminoimidazole derivatives (1)
11/07/2002	WO2002088092A1 2-iminoimidazole derivative (2)
11/07/2002	WO2002088090A2 Pyrazole derived kinase inhibitors
11/07/2002	WO2002088087A1 Novel heterocyclic derivatives
11/07/2002	WO2002088084A1 Heterocyclic compound derivatives and medicines
11/07/2002	WO2002088081A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
11/07/2002	WO2002088080A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088079A2 Dual inhibitors of pde 7 and pde 4
11/07/2002	WO2002088078A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES

1 ... 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 ... 1564